Roger Song
Stock Analyst at Jefferies
(0.84)
# 3,719
Out of 4,396 analysts
250
Total ratings
38.4%
Success rate
-1.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintained: Buy | $41 → $45 | $15.64 | +187.72% | 4 | Jun 8, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $48 | $19.64 | +144.40% | 2 | May 28, 2026 | |
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $52 | $28.67 | +81.37% | 1 | May 26, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $11 | $3.36 | +227.38% | 1 | May 20, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $668 → $733 | $553.14 | +32.52% | 15 | May 19, 2026 | |
| FATE Fate Therapeutics | Initiated Coverage: Buy | $4 | $1.90 | +110.53% | 1 | May 19, 2026 | |
| MANE Veradermics | Maintained: Buy | $75 → $138 | $95.91 | +43.88% | 2 | May 14, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $58 → $71 | $48.70 | +45.79% | 6 | Apr 28, 2026 | |
| ALLO Allogene Therapeutics | Maintained: Buy | $10 | $1.82 | +449.45% | 1 | Apr 15, 2026 | |
| REPL Replimune Group | Downgraded: Hold | $8 → $2 | $9.24 | -78.35% | 15 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $5.78 | +211.42% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $15.80 | +292.41% | 6 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.22 | +334.78% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $2.98 | +436.91% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $66.93 | -32.77% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $41.25 | +203.03% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $371 | $309.75 | +19.77% | 2 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $29.23 | +245.54% | 11 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $11.17 | +276.01% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $154 | $68.34 | +125.34% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $56.23 | +115.19% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $8.81 | +217.82% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $6.13 | +161.01% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $40 | $25.79 | +55.10% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.14 | +340.53% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $17 | $0.4556 | +3,631.34% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4 | $2.70 | +48.15% | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $29.87 | +20.52% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.8 → $1.8 | $1.10 | +63.64% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $2.66 | +952.63% | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.58 | +1,279.31% | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $43.37 | n/a | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $4.30 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $105.87 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.92 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $46.88 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $1.42 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $2.82 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0073 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $18.42 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $97 → $137 | $123.25 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $25 | $8.67 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $4.22 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $18.00 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $29.60 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $3.94 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $104.37 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $2.78 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $7.45 | n/a | 1 | Apr 13, 2021 |
Nurix Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $41 → $45
Current: $15.64
Upside: +187.72%
Kailera Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $48
Current: $19.64
Upside: +144.40%
Avalyn Pharma
May 26, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $28.67
Upside: +81.37%
SAB Biotherapeutics
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.36
Upside: +227.38%
United Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $668 → $733
Current: $553.14
Upside: +32.52%
Fate Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $1.90
Upside: +110.53%
Veradermics
May 14, 2026
Maintained: Buy
Price Target: $75 → $138
Current: $95.91
Upside: +43.88%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintained: Buy
Price Target: $58 → $71
Current: $48.70
Upside: +45.79%
Allogene Therapeutics
Apr 15, 2026
Maintained: Buy
Price Target: $10
Current: $1.82
Upside: +449.45%
Replimune Group
Apr 12, 2026
Downgraded: Hold
Price Target: $8 → $2
Current: $9.24
Upside: -78.35%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $5.78
Upside: +211.42%
Mar 26, 2026
Maintained: Buy
Price Target: $62
Current: $15.80
Upside: +292.41%
Mar 23, 2026
Maintained: Buy
Price Target: $14
Current: $3.22
Upside: +334.78%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $2.98
Upside: +436.91%
Mar 11, 2026
Maintained: Buy
Price Target: $45
Current: $66.93
Upside: -32.77%
Feb 27, 2026
Maintained: Buy
Price Target: $125
Current: $41.25
Upside: +203.03%
Feb 17, 2026
Maintained: Buy
Price Target: $245 → $371
Current: $309.75
Upside: +19.77%
Feb 12, 2026
Maintained: Buy
Price Target: $101
Current: $29.23
Upside: +245.54%
Jan 22, 2026
Maintained: Buy
Price Target: $13 → $42
Current: $11.17
Upside: +276.01%
Dec 19, 2025
Maintained: Buy
Price Target: $154
Current: $68.34
Upside: +125.34%
Dec 17, 2025
Maintained: Buy
Price Target: $121
Current: $56.23
Upside: +115.19%
Dec 10, 2025
Maintained: Buy
Price Target: $28
Current: $8.81
Upside: +217.82%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $6.13
Upside: +161.01%
Sep 9, 2025
Maintained: Buy
Price Target: $80 → $40
Current: $25.79
Upside: +55.10%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.14
Upside: +340.53%
Aug 22, 2025
Maintained: Buy
Price Target: $9 → $17
Current: $0.4556
Upside: +3,631.34%
Aug 20, 2025
Maintained: Buy
Price Target: $12 → $4
Current: $2.70
Upside: +48.15%
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $29.87
Upside: +20.52%
Aug 13, 2025
Maintained: Buy
Price Target: $4.8 → $1.8
Current: $1.10
Upside: +63.64%
Jun 26, 2025
Maintained: Buy
Price Target: $28
Current: $2.66
Upside: +952.63%
Jun 11, 2025
Maintained: Buy
Price Target: $10 → $8
Current: $0.58
Upside: +1,279.31%
May 5, 2025
Reiterated: Buy
Price Target: $46
Current: $43.37
Upside: n/a
Apr 24, 2025
Maintained: Buy
Price Target: $7
Current: $4.30
Upside: n/a
Apr 10, 2025
Maintained: Buy
Price Target: $68
Current: $105.87
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.92
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $46.88
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $1.42
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $2.82
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.0073
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $18.42
Upside: n/a
Dec 20, 2024
Maintained: Buy
Price Target: $97 → $137
Current: $123.25
Upside: n/a
Oct 16, 2024
Maintained: Buy
Price Target: $31 → $25
Current: $8.67
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $4.22
Upside: n/a
Mar 27, 2024
Maintained: Buy
Price Target: $5 → $3
Current: $18.00
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $29.60
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $3.94
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $104.37
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: $23
Current: $2.78
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $7.45
Upside: n/a